Source: http://ipbiz.blogspot.com/2014/08/
Timestamp: 2019-04-20 23:00:47+00:00

Document:
The post includes the text: "the deck may be stacked against American companies in China."
Lee Cowan sits in for Charles Osgood. The cover story is by Martha Teichner. Forbes: best companies to work for. What workers really want. Second, Ather Hussein cameraman from Iraq. Third, Serena Altschul on Christopher Cross. Fourth, Mo Rocca om DC burning by British. Carter Evans on walk in a woods. Faith Salie.
Headlines: European leaders meeting in Brussels discuss Ukraine. Australia prime minister Tony Abbott said Australia will help in Iraq. Heart failure drug. Showboat is closing its doors after 27 years. Michael Sam was cut by St. Louis Rams. California shoppers can't have single use plastic bags. Weather: rain in northeast.
10 million unemployed Americans won't be going back to work on Tuesday. In June, Board of Market Basket dismissed Arthur T. Demulis. Workers protested. Is there a connection between workers feeling well-treated and the bottom line. Robert Levelling: trust creates "family like"/"team like" environment. John Mackey co-founder of Whole Foods.
Fortune started publishing list in 1998. Whole Foods employs 85,000. Employees themselves hire co-workers. Bonuses based on team performance. Louis Carp: store team leader (manager). Being ambassador in a store. "Drinking the KoolAid." According to Gallup survey, only 3 out of 10 workers are engaged. Robert Passan, CWO, of Radio Flyer. Radio Flyer is no. 13 on small company list. There are 64 employees. Little Red Rule: every time we touch people's lives they will feel great about Radio Flyer. Robert Levering. Arthur T. will buy out Arthur S.
Almanac. August 31, 1803. Start of Lewis and Clark's adventure with Lewis leaving Pittsburgh. Camp Wood near St. Louis. Fort Clatsop.
Carter Evans quoting John Muir. Muir Woods National Monument. Glen Plum, biologist. Videocamera on a pole. Bioblitz. 24 hour inventory of species living. Organized by National Geographic and National Park Service.
Mo Rocca. 4000 British soldiers laid siege to Washington, Dc. William Almon, White House curator. William Allen, historian. Corbcob columns of Senate vestibule. Steve Vogel noted slaves were fighting for British. George Coburn.
Reprise of 2002 Joan Rivers interview. A woman of a certain age. Arm candy for Strom Thurmond and the Pope.
You're not wise; it's just that the people who know how stupid you are, are dead.
"Starting Over." Iraqi immigrant who went to Lancaster, PA. KYW in Philadelphia phoned him after seeing Sunday Morning story. An American reality.
Steve Hartman in Spartanburg, SC on Danny (and Ryan (with Down's Syndrome)) Holcomb. Clemson has a program for people with disabilities. Two year program will teach job skills and how to live independently.
Christopher Cross. Ride like the Wind began as a jam.
Faith Salie on taking a holiday. Unplug and re-boot. Time to re-think American work ethic. US does not require paid vacation. Wokers in EU guaranteed 20 vacation days per year. Boldness is not bread and cubicles.
Pulse. What makes your job worthwhile? 52% said co-workers.
Anthony Mason on Tavi Gevinson. Oak Park, Illinois. I'm just a hoarder basically. This is our youth. Steppenwolf Theater. Vogue's Anna Wintur. Movie "Enough Said."
Next week. King of Boardwalk Empire, Steve Buscemi.
Moment of Nature. by Viking River Cruises. Beaver Lake near Buffalo, NY.
CBS Nightly News on Saturday, August 30, 2014 led off with a story on the Novartis drug LCZ696 (a combination of valsartan ( Diovan ) and sacubitril to treat heart failure), which story, including comments by Jon LaPook, was quite favorable.
There was no mention of Diovan having gone off patent.
The experimental treatment, known at LCZ696, cut the risk of both cardiovascular death and admissions to hospital by a fifth, boosting hopes for a product seen as a multibillion-dollar seller - thanks, in part, to its expected premium price.
“Given the survival advantage of LCZ696 over currently available drugs, once this drug becomes available, it would be difficult to understand why physicians would continue to use traditional (drugs) ... for the treatment of heart failure," said Milton Packer of the University of Texas.
Packer was joint-principal investigator on the study with John McMurray of the University of Glasgow, who called the result "astonishing".
The magnitude of the benefit was only disclosed on Saturday, August 30 at the annual meeting of the European Society of Cardiology (ESC) in Barcelona.
See the earlier IPBiz post The PARADIGM-HF study; a new use for valsartan?
"Media corporations exist to assemble audiences for profit, not to inform the public"
Media corporations exist, after all, not to inform the public or help it deliberate but to assemble and re-assemble audiences for profit on any pretext, however sensationalist or degrading, that will assemble them. To keep your eyeballs glued, they’ve become expert at bypassing your brain and the heart on the way to your lower viscera and your wallet.
In context, "media corporations" here are things like -- Time, The Washington Post and CNN --.
And thus the media corporations might be turning a "blind eye" to the problems with Zakaria's work: Whenever he has passed off someone else’s work and authorial voice as his own, he has crossed a line that Time, the Post, and CNN shouldn’t be blurring as shamelessly as they’ve been doing.
However, the argument could be extended even to scientific journals.
of aliphatic carbon (sp3 hybridized carbon). Pertinent prior work on diffraction of "poorly crystalline"
carbonaceous systems with sp2 and sp3carbon was ignored.
key assumption was re-characterized as the existence of amorphous and crystalline phases in the coal.
or on any other system.
self-citation or channeling. For more details of the scientific and citation issues involved, see L. B.
Ebert, Petroleum Science & Technology, 1997, 15, 171-183.
Science journals, as the magazine Time, are a business. And the first order of business is to protect the business.
Even if that means turning a blind eye to the truth.
Returning to Zakaria matter, as to the one point of plagiarism, "unattributed copying" is plagiarism, no matter "who" identified it and no matter "why" it occurred. The "who" and the "why" may be newsworthy, but they are not defenses to plagiarism.
The PARADIGM-HF study; a new use for valsartan?
The release of PARADIGM-HF trial, with its stunning results for Novartis’ combination drug, is good news for patients with heart failure and their doctors. The trial was ended early because the combination drug, which included sacubitril (an experimental drug) and valsartan (a current therapy), demonstrated superiority over enalapril (another current therapy).
Heart failure is primarily a condition that affects the elderly. In PARADIGM-HF the average age was 64 years old, considerably younger than the typical patient with heart failure. The study also excluded patients with decreased kidney function. This situation is not unlike what we have seen in other trials of heart failure, including those that are the foundation for what is now considered standard therapy.
What will we do to ensure that once the drug is approved, that the learning about it does not stop?
The published article states that the sponsor, Novartis, collected, managed, and analyzed the data. The article states that the analysis followed a pre-specified plan and that an independent academic statistician replicated the analyses. However, it is not clear whether that person had access to all the raw data and forms and to what extent the statistician could assess what was done by the company.
Whether angiotensin receptor blockers may or may not increase the risk of myocardial infarction (heart attack) was announced in BMJ and was debated in 2006 in the medical journal of the American Heart Association. To date[when?], there is no consensus on whether ARBs have a tendency to increase MI, but there is also no substantive evidence to indicate that ARBs are able to reduce MI.
EFF re-visits Hwang Woo Suk; perhaps an award for stupid comment of the month?
As such, Grimmelmann's remark about howitzers is incredibly stupid in the context of US 8,647,872. If the work is fraudulent, it would be impossible to infringe the claims to a non-existent cell line.
questionable actions by one Glenn A. Ballard Jr. who misrepresented facts to federal judge Keith Ellison.
The patents in question were to Tesco inventor Kevin J. Nikiforuk. The infringement defendants found a sales brochure of Tesco, prepared more than one year before application filing; Nikiforuk, examined the brochure and acknowledged it was his.
At this point, Ballard asked the judge for additional time.
He came back on Monday morning claiming his firm talked to two men who did the illustration of the tool for the marketing brochure and they assured him, "unequivocally," it was not the same tool at issue in the case. (...) "I think the issue has been put to bed," Ballard assured U.S. District Judge Keith Ellison, adding that both animators were prepared to swear to it in court. "… In fact, there is no doubt it's not Mr. Nikiforuk's invention."
At the time, Judge Ellison took Ballard at his word, as federal judges with heavy caseloads are sometimes forced to do. Trust is essential in a system that relies upon attorneys to produce evidence.
In fact, the judge decided this week that Ballard was lying to his face.
Ellison, known as a fair, mild-mannered jurist, imposed the so-called "death penalty" of the civil court system on Tesco and counsel. He dismissed the now-6-year-old case with prejudice, meaning it can't be refiled. And he opened the door for awarding attorney fees for the other side, which could total several million.
In his order, Ellison takes the company to task as well, writing that Tesco's misrepresentations "irrevocably poisoned these proceedings" and amount to "an abuse of the judicial system."
Cattle feed as a "new" application for algae?
In Australia, algae may have a new application: cattle feed. Research sponsored by Meat and Livestock Australia and conducted by the University of Queensland was unveiled last week, debuting an on-farm algae growing prototype in Queensland.
How "new" this application may be is open to question.
Contemplate text in US 3,951,805 (issued in 1976): The ultimate aim is primarily to remove the algae and the fibrous material as an entity from the machine and to utilize the removed materials as an entity for cattle feed. The inventor Joseph Dodd was from Werribee, Victoria 3030, Australia .
Melbourne, Fla.-based PetroAlgae Inc. has changed its name to Parabel Inc. According to information released by the company, the new name better reflects its strategic changes and commercial milestones.
Information issued by Parabel noted that its proprietary technology addresses global demand for new sources of feed, food and fuel. According to the company, its open-pond bioreactor technology enables customer licensees to grow, harvest, and process locally available, aquatic microcrops. Biorefining Magazine’s prior coverage of the company notes that the Parabel’s technology is used to cultivate microcrops from the Lemnaceae family, including duckweed.
Dried duckweed can be a good cattle feed. It can contain 25-45% protein (depending on the growth conditions), 4.4% fat, and 8-10% fiber, measured by dry weight.
Contemplate also text from US Patent 8,343,753 : For example, in some embodiments, when used as animal feed (e.g., cattle feed, dairy feed, aqua feed, poultry feed), the one or more PUFAs produced by the microalgae can be incorporated into the flesh or other products of animals including, but not limited to, livestock, poultry, cattle, and fish. The PUFAs also can be used for pharmaceutical or nutritional purposes and industrial applications.
It is an object of the present invention to provide a new and improved method and system to create and use an algae based food supplement for but not limited to beef cattle.
Namenda ( memantine; 3,5-dimethyladamantan-1-amine. an adamantane derivative ) is a drug marketed by Forest for the treatment of Alzheimers. CBS network news on August 28, 2014 did a story on a "forced switch" created by Forest, making patients who were using the previous formulation change over to Namenda XR, by stopping production of the previous drug. Jon LaPook presented the story, which suggested that the motivation was the continued patent coverage on Namenda XR.
Forest had made an announcement on February 14, 2014: Forest Laboratories, Inc. (NYSE:FRX), a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, today announced that it plans to discontinue the sale of NAMENDA® (memantine HCl) 5 mg and 10 mg tablets effective August 15, 2014. Forest has notified the U.S. Food and Drug Administration of this decision. The oral solution of NAMENDA and once-daily NAMENDA XR® (memantine HCl) extended-release capsules will continue to be available. Both NAMENDA and NAMENDA XR are indicated for the treatment of moderate to severe Alzheimer’s disease.
It was of interest to note that commercials on CBS following the story included for Levemor (Novo Nordisk) and for Brisdelle (Noven, low dose paroxetine).
Fifty-four-year-old Michael Hitch of Maryville, Tennessee, has early onset dementia and says he is helped by an Alzheimer's medication called Namenda. The drug is due to go generic next year.
But Forest Laboratories, the company that makes Namenda, plans to stop the sale of the version that Hitch takes at least six months before a less expensive, generic product could become available.
The purpose of a forced switch is "to get patients over to this new product as fast as possible," said David Maris, a stock analyst with BMO Capital Markets who covers pharmaceuticals. Thus, when the patent ends on the old product, "patients are already on the new product and there's no existing product left."
"All of a sudden you don't have that cliff, you don't have a drop off in sales like you would otherwise," Maris said.
Hot peppers deterring insects but encouraging anti-patent crowd-funding?
Endnote 17: On his website, Jim teaches using 4 tablespoons of pepper powder, 1 tablespoon of dishwashing detergent with one gallon of water, steeping overnight, straining and spraying on insects. The Pacific Northwest District of the American Rose Society also notes that hot pepper sprays are insecticides and there has been experimental research on extract of capsicum frutescens as a natural insecticide in Natal, Botswana and Zambia and traditional uses in Zimbabwe, Kenya, and Uganda. Separately, there is a report that Grady Glen, of Texas A&M, used Habaneros on wood to deter termites.
This Kat has received information concerning the publication in a national Dutch newspaper of a double page item calling for crowd-funding of opposition proceedings against a European patent. The patent in question, granted last year to Syngenta, relates to EP2140023 relating to insect-repellent pepper plants.
John P. Walsh and Wei Hong, "Secrecy is increasing in step with competition," Nature, 2003, 422, 801-802. In a cross-section of biologists, mathematicians, and physicists, the authors noted that willingness to talk about research had gone from 50% in 1966 to 26% in 1998. One notes that the Rosalind Franklin/DNA episode had already occurred by 1966. The authors suggested that focus on commercialization [of academic work] as the cause of secrecy is misplaced. While I would agree that informal industry/academic collaborations actually foster greater openness, I would suggest that industrially-sponsored academic programs do enhance secrecy, although the data indicate separately that there is already a high baseline of secrecy created by intra-academic competition. See L. B. Ebert, Implicitly Zurko, Intellectual Property Today, p. 22, July 1999. As one footnote, note that the pivotal "research exemption" case of Madey v. Duke University, 307 F.3d 1351 (CAFC 2002), arose from intra-academic competition and disagreement, although the legal decision may impact industrial/academic interaction. See also, Rebecca Eisenberg, "Patent Swords and Shields," Science, 2003, 299, 1018 ["As universities have become increasingly aggressive as patent owners, they have compromised their claim to disinterested stewardship of knowledge in the public interest."] and John P. Walsh, Wesley M. Cohen and A. Arora, "Working through the Patent Problem," Science, 2003, 299, 1021. Separately, note that Genentech sued Columbia University in April 2003. See Paul Elias, AP, Suit Against Columbia University Highlights Issues of University Patents, April 28, 2003. Separately, note the issues with the Ponikau/Mayo patents such as US 6,207,703 as discussed in Peter Landau, Critics Turn Up Noses at Mayo's patent for inflamed sinus cure, Wall St. Journal, May 1, 2003.
In that 1945 period, physicist Philip Morrison noted that the desire to patent results would spread from industrial labs to the universities and destroy the traditional free cooperation of science, an argument re-cycled into the 21st century.
As noted in the text, the idea that depletion of nitrogen nutrients causes an increase in lipid content is known.
tested species showed a significant rise in lipid production. A detailed and large-scale model of lipid induction by nutrient starvation (nitrogen, phosphorus) on several diatoms, green algae, red algae, prymnesiophytes and eustimatophytes is presented in a study carried out by Rodolfi et al. .
 Much research has been conducted over the last few decades regarding using microalgae as an alternative and renewable source of lipid-rich biomass feedstock for bio fuels. Microalgae are an attractive model in that they are capable of producing substantial amounts of lipids such as TAGs and DAGs under stress conditions, such as nitrogen starvation. However, a decrease in growth of the microalgae under nitrogen starvation makes it harder to use microalgae in the large scale production of biofuels.
In other cases, the algae may be subjected to environmental stress conditions designed to enhance lipid production, such as nitrogen starvation or other nutrient deficient conditions. The amount of nitrogen in depleted media may vary from 0 to 75% of the normal amount, depending on the medium used and the type of algae to be stressed.
 Under optimal growth conditions, diatoms and other microalgae synthesize fatty acids primarily for esterification into glycerol-based membrane lipids, which constitute about 5-20% of their dry cell weight. However, under unfavorable environmental conditions, such as during nitrogen deprivation, many algae shift their lipid profile towards the formation and accumulation of neutral lipids, principally in the form of triacylglycerol. Under such unfavorable growth conditions, the total lipid composition of certain microalgae can increase to above 50% of the algae's dry cell weight.
One issue is that the desired target is increasing total lipid produced (say per unit time and/or per surface area), not simply increasing lipid per biomass. Another issue is that the organic phase from the biomass (obtained for example through hydrothermal liquefaction) still contains nitrogen, which is undesirable for biofuels.
Here, eBay is using a Texas anti-SLAPP statute to shield it from litigation from Landmark arising from eBay's re-examination request.
CAFC in Ferring v. Watson: " but silence does not answer the question of infringement "
There was good news and bad news for Ferring in the case involving Watson concerning Lysteda® .
The good news: the claims were not obvious. The bad news: Watson did not infringe.
The determination of non-obviousness was direct.
have not been shown to be invalid under §103.
sdictional purposes. J.A. 2192–93, 2248–56, 2316.
1348, 1365 (Fed. Cir. 2003); Abbott Labs. v. TorPharm, Inc.
Squibb Co. v. Royce Labs., Inc. , 69 F.3d 1130, 1135 (Fed.
Ferring relied on experimental outliers for infringement.
Becton Dickinson & Co. v. C.R. Bard, Inc.
thus containing all the limitations of) that claim.”).
Planet Bingo lost under 35 USC 101 both before and after Alice v. CLS, 134 S. Ct. 2347.
In the case, no difference was found between method and system claims.
Mayo Collaborative Servs. v. Prometheus Labs., Inc., 132 S.
Looks like they have substantial investment in patent protection. They seem to have plenty of resources. It would be interesting to know what level of vacuum is needed. Manufacturing under vacuum would reduce contamination. Since they are not resource limited, designing to manufacture in a vacuum chamber shouldn't be a deal breaker. Sounds like they might pull it off.
In fact, there are 24 published US applications including the word --Sakti3 --.
 In a specific embodiment, the solid-state glassy electrolyte of this electrochemical cell device comprises amorphous lithiated oxynitride phosphorus with ionic conductivity ranging from 10.sup.-5 to 10.sup.-4 S/m. The ionic conductivity of glassy electrolyte can be tuned by the nitrogen concentration and evaporation process conditions. This glassy electrolyte material can be configured as an electrolyte overlying the cathode electrode material. This glassy electrolyte material is capable of shuttling lithium ions during a charge process and a discharge process, and is characterized with layer thickness between about 0.1 and about 1 micrometers.
 The results of the invention are a solid state battery that has energy density above 300 Wh/L. Although this has been achieved using some battery systems that are designed with liquid or gel electrolytes, no solid state batteries with ceramic electrolytes have come close to achieving this level of energy density. Furthermore, the ceramic electrolytes and the design that is employed by Sakti3 eliminates the occurrence of lithium dendrites and other undesirable side reactions that occurs between the liquid or gel electrolyte and the battery materials in conventional wound lithium-ion batteries. Additionally, the solid ceramic electrolyte that is utilized in this invention also eliminates the occurrence of internal short circuits that are a major failure mechanism in lithium-ion battery cells that utilize a polymer separator.
 The potential benefits of solid state batteries with ceramic separators have been discussed for over a decade, but to date few have truly commercialized this product. One challenge that plagued the commercialization of this product is the development of product design parameters with high levels of performance. Another challenge that has not been previously overcome is the development of a roll-to-roll production process that is required to make larger format-sized (greater than 1/10.sup.th amp-hour) solid state batteries and winding them and packaging them in a format that can power products that require greater than a micro-amp of electrical current.
It’s important that Mr. Issa take a hard look at how the office is being managed.
The opening is in Santa Fe, with a special edition from Charles Osgoode. Anthony Mason does the cover story. Living Large. Second, mobile homes. Third, Rita Braver interviews Venus Williams. Fourth, Serena Alschul on the mysteries of duck tape. Fifth, John Blackstone. Lee Cowan. Tracy Smith.
Don Daylor in the newsroom for headlines. 6.0 earthquake near American Canyon, near Napa, CA. Obama orders a review of programs on used military gear to police. On Staten Island, march about Eric Garner.
Israel pounds Gaza. Joshua Houston helps Chicago beat Las Vegas. Weather: hot and humid in west.
Luminous landscape in northern New Mexico. La Luz. In 1610, Santa Fe established. Oldest state capitol city in US. The Kline residence. Anthony Mason and Mark Strassman. Woolworth Skyscraper in NYC. to be made into 34 condos. Alchemy Properties. Tierre des Fon. Ultra luxury market is booming. Robert A. M. Stern. New York's Perry Street. Richard Meyeer architect. The Surf Club in Miami BEach. Price is $35 million. Number of billionaires is increasing. Competition for better units is fierce. Copper domed cupola of Woolworth will be five story penthouse.
Atocha Mobile Home Park owned by Eduardo Ramirez in Santa Fe. Trailer trash, but hardworking.
There are 8.5 million mobile homes in US. 97% of mobile homes never move again. Mike Bustamente is mobile home guy in Santa Fe. Jennifer Siegel innovator in mobile design. The future of what the trailer can become. Paradise Mobile Home in Malibu, CA. 7 figure prices. Homeowners rent land which can be $3000 per month. Sense of community in Paradise Cove. Marty King is a contractor.
Santa Fe's historic plaze; Osgood's tie made of duck tape. Serena Alschul. Prom clothers from 42 rolles of cuk tape. How to paint a pictue with duct tape. Duck brand duct tape from Avon, Ohio. Scott Summers. Move duct tape from hardware stores craft shops. Permicell Division of J&J: tape for coverning ammunition. Housing boom of 1950's: duct tape.
Maria Benitez and Joaquin Gallegos. Santa Fe Opera.
Martin DuBois, architect. Richard Schlesinger. Thatcher Wine on bookcover design. Custom design libraries. Juniper Books in Boulder, Colorado. Bespoke Libraries. Custom library for $750 per foot.
Used law books for "picture window" design. Don't want people to use them. Cool and practical.
Mo Rocca. There are no words. On Emoticons. Sept. 1982. Scott Fahlman at Carnegie Mellon. 19Sept1982. Imogees. Matt Weinberg; Vector Media Group in NYC. Custom Emoticons. A personal emoticon.
Tracy Smith on transportation. Nashville as source of skateboards. Salemtown board company.
Klein House in Santa Fe. Seth Doane goes to Bali. Houses of bamboo. Laura Hardy. Jewelry designer John Hardy. The Green School: think about impact on environment. Inspiring magical place. Ibuku brand. Peter Barge. Sharma Springs.
Rita Braver on Venus Williams. Jupiter, Florida studio.
Mo Rocca on "treadmill desks." Joanna Coles: sitting is the new smoking. By the 1800s chairs were everywhere. Joanna does 2 miles per hour. Steelcase is largest maker of office furniture. LifeSpan.
Never go on it when you are drunk.
Moment of nature. spiriva. Red rocks near Abiquiú, New Mexico. This is location where the opening shot of the Kingdom of the Crystal Skull was shot, as well as parts of "Red Dawn" (which nominally was supposed to be in Colorado).
asserted claims of the ’917 patent, we affirm.
256 F.3d 1323, 1342 (Fed. Cir. 2001)(citation omitted).
CAFC explores double-patenting in Abbvie v. Kennedy Institute; Kennedy loses.
In Abbvie v. Kennedy Institute;, Judge Dyk gives an expansive review of double-patenting.
two inventions are patentably distinct.
court here relied on any such principle.
its genus. See Eli Lilly & Co.
v. Bd. of Regents of Univ. of Wash.
Perricone v. Medicis Pharm. Corp.
What is a reasonable interpretation of the teachings of the prior art?
To be clear, we agree with Apotex that Dr. Sherman had no duty to disclose his own suspicions or beliefs regarding the prior art. There is nothing wrong with advocating, in good faith, a reasonable interpretation of the teachings of the prior art. The misconduct at issue, however, goes beyond failing to disclose a personal belief or alternative interpretations of the prior art; here, Dr. Sherman affirmatively and knowingly misrepresented material facts regarding the prior art.
As to intent, the Federal Circuit states that "[Dr. Sherman] knew enough to recognize that he was crossing the line from legitimate advocacy to genuine misrepresentation of material facts."
Finally, the Federal Circuit did not reach the "egregious misconduct" determination because the evidence of materiality and intent were sufficient and thus the District Court's inequitable conduct determination was not an abuse of discretion.
As to the point about "advocating," IPBiz notes the CAFC cited Rothman v. Target Corp.
The boundaries on a patent attorney's conduct are not so narrow, however. While the law prohibits genuine misrepresentations of material fact, a prosecuting attorney is free to present argument in favor of patentability without fear of committing (p. 1329) inequitable conduct. See Young v. Lumenis, Inc., 492 F.3d 1336, 1348 (Fed. Cir. 2007) ("We therefore fail to see how the statements . . . which consist of attorney argument and an interpretation of what the prior art discloses, constitute affirmative misrepresentations of material fact."). This court has little basis to find deceptive intent in the routine back and forth between examiner and applicant. Moreover, this court recognizes that the Patent Act gives the examiner the discretion to reject or accept an applicant's arguments based on the examiner's own conclusions regarding the prosecution record.
In any event, this type of conclusory analysis betrays no intent to deceive the PTO and obtain a patent with objectively false information. Rather, it is an attempt to characterize the prior art in a manner favorable to the attorney's client — far from deception. No reasonable jury could rely on Mr. Jacobson's statements as clear and convincing proof of inequitable conduct.
Forbes criticizing Forbes on patents; one poseur dumping on another poseur?
Patent trolls exist, yes, patent trolls are largely non-proactising entities, yes, but it does not therefore follow that all NPEs are patent trolls. Let me take a hypothetical example. We have a university (we might call it “Harvard” for example) where professors and students create a new drug with interesting properties. They patent it. This is actually the sort of thing that happens quite a lot actually, small research organisations (whether universities or not) find something of interest. They’ve absolutely no intention whatsoever of trying to take that drug to market though.
Gene Quinn wrote in 2010: I hate the term patent troll because it has over time become synonymous with “non-practicing entity.” Not all non-practicing entities are bad though. For example, universities are non-practicing entities but the research they do is fundamentally important to our economy.
Harvard, or the little corporation Harvard sets up, are clearly an NPE here. But they’re in no manner a patent troll if they do end up suing someone for breaching their patent. And that’s where I spot the error in this paper.
Perhaps Worstall needs to review the Ariad/Lilly and Rochester/Searle cases to see the error in Worstall's thinking.
And then Universities licensing to patent trolls?
Renewed charges of plagiarism against Zakaria made by Our Bad Media include lifting full paragraphs and copying a single sentence and copying facts and figures produced by the research of others.
The Post’s editorial page editor, Fred Hiatt, said the Post column alleged by Our Bad Media to contain plagiarism or failure to use attribution did not constitute any journalistic offense.
Of the 500 big companies in the well-known Standard & Poor’s stock index, 115 paid a total corporate tax rate — both federal and otherwise — of less than 20 percent over the last five years, according to an analysis of company reports done for The New York Times by Capital IQ, a research firm. Thirty-nine of those companies paid a rate less than 10 percent. – David Leonhardt, New York Times, February 1, 2011.
Cain's second 9 is a 9% rate for corporate taxes, except that it's not really a corporate tax but a business-transaction tax. Still, the basic idea has value. The U.S. today has the second highest corporate tax rate in the industrialized world. And yet, of the 500 big companies in the Standard & Poor's stock index, 115 paid a total corporate tax rate--both federal and otherwise--of less than 20% over the past five years. Thirty-nine of those companies paid a rate of less than 10%. – Fareed Zakaria, “Complexity Equals Corruption," October 31, 2011 Time.
There's no lifting of language, and I'm sure I could find the same data in a dozen other reports. I honestly think it is reckless even to suggest this is plagiarism.
which is a useful guide for understanding "inequitable conduct" post-Therasense.
from Schwarz Pharma under the trade name Univasc.
In all, the Examiner made three rejections, and Apotex appealed to the Board.
The CAFC appeal related to a lawsuit filed by Apotex against UCB on April 20, 2012.
The district court had found inequitable conduct on the part of Apotex.
Lastly , the district court found that Dr.
the prosecution of the '556 case.
vance to the prosecution of the ‘556 patent.
the prosecution of the ’556 patent.
ing of but-for materiality was not necessary because Dr.
consequences of the past-tense use or of not citing the PCT.
production of prostaglandin E2 (PGE2)  and nitric oxide (NO).
litigation has a negative real impact on the future innovative activity of targeted rms.
idea's owner sole commercialization rights for a period of time.
Forbes dipping into yellow journalism on patent reform?
The bigger problem, as we discussed, is that many of the patents should probably never have been granted in the first place. The U.S. patent office in particular has in the last ten years been so overwhelmed with applications that they grant patents for inventions that are anything but, leaving it to the courts and so-called “patent trolls” to sort out which ones really deserved legal protections and which ones were too obvious.
Why has the patent office become so generous with such dubious applications? Last week there were reports of an internal investigation at the patent office, initially suppressed, that revealed widespread fraud by patent examiners, nearly half of whom work from home full time, of inflated hours and unearned bonuses.
While that report (and the attempt to cover it up) are pretty shocking, chaos at the patent office is just the tip of the iceberg. Between the courts, the patent office, and abusive litigation, the U.S. patent system is in dire need of reform. Congress keeps trying, but can’t seem to pass anything of substance—on this or any other subject.
Does the article imply that the business with telecommuting caused the patent office to be generous in granting patents on dubious applications?
Did the USPTO "attempt to cover up" the first report? The same author wrote both reports.
Even assuming everything in the first report is true, did this behavior cause improper patent grants?
"Patents are for the limitation of invention"
The text "Patents are for the limitation of invention" might seem to be from patent reformers of the 21st century. In fact, it came at a 1945 conference, and arose from one Harry Grundfest. The background debate concerned "how" government funding of science would be conducted post-World War II. A bill by Senator Kilgore proposed that patents from government-funded work would inhere in the federal government. A different bill by Senator Magnuson, which was favored by Vannevar Bush, left patent rights the way they were. A compromise bill was created, but the House offered an alternative that Vannevar Bush backed. The creation of the NSF was delayed for four years, in part because of the issue over patent rights. When Congress sees significant differences of opinion, it does not act, whether in 1945 or in 2005. In that 1945 period, physicist Philip Morrison noted that the desire to patent results would spread from industrial labs to the universities and destroy the traditional free cooperation of science, an argument re-cycled into the 21st century.
Homer Simpson sued for patent infringement?
Use of a 3D representation of Homer Simpson at this year's Comic-Con convention in San Diego has produced a patent infringment suit by Alki David's Hologram USA .
There has been some discussion of whether or not a book titled “The Invisible Bridge: The Fall of Nixon and the Rise of Reagan” by Rick Perlstein improperly borrowed from a book by Craig Shirley .
As a first matter, one needs to disconnect "plagiarism" from "political attack." For example, one suspects the charges against Senator John Walsh were politically motivated, but that motivation does not negate the plagiarism of John Walsh. Similarly, the charges against Glenn Poshard were politically motivated, but Poshard did plagiarize within his Ph.D. thesis.
As a second matter, the procedure of separating identifying endnotes/footnotes from the related text is problematic when the endnotes are placed on a pliable web and the related text is not. Things on the web can be changed, or simply disappear. Thus, putting endnotes onto the web is not all right.
http://ipbiz.blogspot.com/2008/12/nj-superior-court-judge-wilbur.html [The article by Judge Mathesius that provoked the uproar seems to have vanished from the internet, likely another Sikahema.
Even LEXIS will alter reported decisions without reference to the earlier, now altered, decision.
This is bizarre... you write a followup to the PTO article and still don't clarify that our work is monitored extremely closely every biweek and that everything we do is a matter of public record. If anyone has a serious question or issue with the quality of our work they can look at it.
The only issue is the question of how close an accounting of day to day, hour to hour activities is necessary for PTO management and appropriate for GS 12-14 employees who are meeting all of their production goals. Some managers want better tools to discourage end-loading or perceived shirking... Examiners, as a rule, want to be allowed to work on their own schedule (within reason).
- For each Office Action an Examiner writes, he/she gets a certain number of hours to complete that work.
- The number of hours allotted is based on the technology area and Examiner tenure, to account for varying complexity and experience.
- The metric used to judge Examiners is "Counts", which can be earned in a variety of ways, with diminishing returns in some cases, but issuing an Action is the most common Count.
- If an Examiner becomes good at their job, they become efficient, and can complete an Action in less than the allotted time.
- Ideally, the efficient Examiner then moves onto the next application, earning more Counts; when he/she gets ahead of their expected Count production, they move into earning what is effectively overtime pay.
- BUT this is the Government, and somebody (*cough* Congress *cough*) has from time-to-time forbidden overtime work because they don't want to pay for it.
- So, the Examiner is presented with a choice: (1) do more work and get chastised on your employee record for trying to earn "overtime" pay (and making everyone else look bad), (2) work slowly to fill out their hours with exactly as many Counts as they are "supposed" to be producing, (3) do the work efficiently and account for time accurately, then get penalized for not working the required number of hours, or (4) do the work efficiently and just plug in the hours expected of such work, leaving yourself some free time.
The rational actor chooses to do the work efficiently, plug in the expected hours, and get free time. Is this a systemic problem? Yes, obviously. But fault lies more with agency administration and Congressional monkey-wrenches than with most individual Examiners.
If I ever worked at a place where I was chastised for making others look bad because I was good at my job, I'd quit. But, I agree with you in that the incentive (and disincentive) structure needs to be such that good behavior is rewarded and bad behavior is punished. They can't simply depend on the ethics of their workforce.
See The great-grandchildren of the woman who once served as Aunt Jemima filed a class action suit seeking royalty back payments.
Hunter’s lawsuit accuses the companies of lying to cover up Quaker Oats’ employment of Harrington, adding that the heirs determined they were owed royalties when they say they discovered last October that the company had trademarked the image of their great-grandmother with the U.S. Patent and Trademark Office in 1937 and after they found a death certificate for Harrington that named the company as her employer. Hunter has accused the companies of breach of contract, conspiracy, and fraud, among other charges, while alleging that Quaker Oats engaged in “industrial espionage” to procure Harrington’s trade secrets before failing to compensate her estate on an annual basis following her death.
This would easily encompass copying ideas from US published patent applications which have no counterpart in China. Patent protection in the US does not extend to protection in China. No need for hacking into computer systems.
When Google bought Nest Labs for $3.2 billion seven months ago, I described the move as the start of a home invasion. Google already knows a lot about you, including where you live, what your interests are, where you go on the Internet and in the real world (via Android), and its acquisition of Nest, which makes smart thermostats and (not so smart) smoke detectors, meant it would potentially also know what you get up to in your own home.
As it turns out, Google using Nest products to find out what customers are doing is just one worry. A team of researchers has discovered an easy hack that allows anyone to gain control of Nest’s smart thermostat and turn it into a spying device which can reveal when you’re at home or away, and even divulge your Wi-Fi credentials.
The work was done by University of Central Florida students and reported at the Black Hat security conference in Las Vegas.
Essentially, all the attacker has to do is hold down the power button and insert a USB flash drive in order to enter developer mode. From there, they can load a custom compiled kernel to gain access to the software protocols used by the device.
the researchers said, "Although OS level security checks are available and are claimed to be very effective in defeating various attacks, instead of attacking the higher level software, we went straight for the hardware and applied OS-guided hardware attacks. As a result, our method bypasses the existing firmware signing and allows us to backdoor the Nest software in any way we choose". This includes introducing rootkits, spyware, rogue services and other network scanning methods.
"Entering into that mode allows you to upload your own code, your custom code, which allows you to attack existing code, implant your own and reboot normally, but maybe have something else running in the background," Hernandez adds. "We have access to the device on the highest level, and we can send stuff that Nest sends to us as well".
contained threatening, false , and misleading statements.
MPHJ removed the case to federal court (No. 2:13-cv-00170, D. Vt.), arguing that it involved issues of patent law implicating a federal question, as well as asserting that diversity existed between the State of Vermont and MPHJ.
Yesterday, Federal District Judge William K. Sessions III rejected those arguments and ordered the case back to Vermont state court. Judge Sessions rejected the diversity argument quickly, citing the well-established principle that a state is not a “citizen” for diversity purposes. He further held that the AG’s suit based on harm allegedly caused to individuals and businesses did not render those individuals and businesses “real parties-in-interest” for diversity purposes.
Next addressing the federal question argument, the Court held that the state’s complaint is based entirely on Vermont state law, not federal patent law.
While this decision stands as a victory for AG Sorrell, the case itself is far from over. As the Court noted, MPHJ has asserted constitutional and federal patent law defenses—as it also has in litigation against Nebraska AG Jon Bruning and the Federal Trade Commission seeking to invalidate enforcement actions similar to Vermont’s—that remain pending. The expected substantive decision on those issues will have a far-reaching impact not only on AG consumer protection authority, but on the broader national debate of striking the right balance to protect intellectual property, limit abuse of the judicial system, and encourage innovation and economic growth.
Without deciding any other motions, the district court granted the State’s motion to remand. The district court stated that the complaint did not raise a substantial question of patent law, and that “the State is targeting bad faith conduct irrespective of whether the letter recipi- ents were patent infringers” or the patents were invalid. State of Vermont v. MPHJ Tech. Invs., LLC, No. 13-cv- 00170, slip op. at 14 (D. Vt. Apr. 14, 2014). The court pointed out that MPHJ’s preemption assertion was a defense to its allegedly unfair and deceptive practices, and that a defense cannot provide a basis for federal subject matter jurisdiction. See Metro. Life Ins. v. Taylor, 481 U.S. 58, 63 (1987).
MPHJ appeals the remand to state court, and has filed a petition for a writ of mandamus.
The Supreme Court has held that this provision ap- plies only to remands based on the grounds specified in § 1447(c)—namely, a defect in removal procedure or lack of subject matter jurisdiction. Thermtron Prods., Inc. v. Hermansdorfer, 423 U.S. 336, 343–45 (1976). In Kircher v. Putnam Funds Trust, the Court stated that “we have relentlessly repeated that ‘any remand order issued on the grounds specified in § 1447(c) [is immunized from all forms of appellate review] . . . .’” Kircher, 547 U.S. 633, 640 (2006) (citing Thermtron, 423 U.S. at 351).
Section 1447(d) pre- cludes this court from second-guessing the district court’s jurisdiction determination regarding subject matter. If the § 1447(d) bar applies, “review is unavailable no mat- ter how plain the legal error in ordering the remand.” Briscoe v. Bell, 432 U.S. 404, 413 n.13 (1977) (citing Gravitt v. Sw. Bell Tel. Co., 430 U.S. 723 (1977)).
jurisdiction determination regarding subject matter. The remand stands, even if the reasoning was faulty.
The patentee appealed an unfavorable decision by PTAB in re-examination of claims related to "A system for restricting access to television programs." The CAFC affirmed obviousness.
Teva Pharmaceutical Industries intends to file a Hatch-Waxman infringement law suit against Dr Reddy's Laboratories related to Reddy's paragraph IV filing as to the patents of Copaxone (glatiramer acetate) injection 40mg/mL.
Copaxone is the subject of the pending Supreme Court case between Teva and Sandoz involving a dispute over claim language asserting molecular weight. The United States Supreme Court rejected Teva's application for an injunction seeking to prevent launch of a generic version of Copaxone involving Natco Pharma.
A letter of August 6, 2014 to Dept. of Commerce Secretary Pritzker from five Senators has a first sentence including the words "high quality patents." The second sentence has the words "patent trolls." Footnote 2 cites to Nautilus v. Biosig and to In re Packard.
The fifth signatory to the letter is that of Mark R. Warner, the senior senator from Virginia.
Turkey hunting, NASCAR and a bluegrass campaign ditty: not the most obvious path to the governor’s mansion for a multimillionaire raised in Connecticut. Yet it worked for Mark R. Warner, running in Virginia in 2001, and still looks like a stroke of genius to many an admiring Democrat.
A computer-implemented secure-bidding process comprising: providing a broker user interface on a computer system that elicits and receives information from one or more brokers to setup a plurality of bid processes including a first bid process, administers a database of bidders on the computer system, and performs one or more reporting functions; defining, in the computer system, an expiration time for a bid period of the first bid process; electronically receiving into the computer system a plurality of bids submitted by a plurality of bidders for the first bid process only at times before the expiration time for the first bid process; encrypting, in the computer system, the plurality of bids for the first bid process upon receipt or earlier to form a plurality of encrypted bids; automatically generating and logging at least one digital checksum, in the computer system, for each of the plurality of bids received for the first bid process; securely storing on the computer system the plurality of encrypted bids in a secure electronic vault, wherein the vault includes a directory in which specific information, including encrypted bids and digital checksums, about each one of the plurality of bid processes is automatically retained, and wherein the specific information for the first bid process is retained in an inaccessible state until the expiration time of the first bid process; decrypting using the computer system and delivering to one or more transaction participants bid information for the first bid process from the vault only following the expiration time of the first bid process; receiving into the computer system a bid summary report based on the decrypted bid information and a decision from the one or more brokers to award the first bid; delivering the bid summary report to the plurality of bidders for the first bid process; and using the computer system, automatically creating an electronic archive of information relating to the plurality of bid processes, including the encrypted bids and the bid summary report, for the first bid process, wherein the electronic archive of information includes the digital checksum information.
Washington Post discloses internal USPTO report critical of Patent Office teleworking program; next probe: "are the examinations accurate?"
Investigators found a lax system for monitoring employees who work from home — some as far away as California. Examiners do not have to log into the agency’s computer network or tell their supervisors the hours they work. They do not have to respond to a phone call from their boss the same day it comes in.
I have no knowledge of whether or not patent examiners cheated. HOWEVER: 1) You can't tell if patent examiners are working by monitoring their computers. That is just stupid. The examiners could be reading printed-out material, and making hand-written notes on it. They could be walking around, debating pro/con points in their heads. Examiners could be on the phone with somebody. 2) Even if you could keep track of exactly what the examiners are doing, all day long, that still wouldn't be proper supervision, because some examiners are simply more efficient than others. They should (and do) get judged by throughput, not by time served. The supervisors ought to be spot-checking the throughput for quality, not trying to play "time-clock gotcha" with professionals.
That's not how the USPTO works. A supervisor does not have to sign an action if he doesn't agree with it. Examiners are on production. If you fall below and stay below, you get fired. It's very clear. You refer to the article, but the article isn't worth the memory it's stored on. Too many falsehoods and half-truths.
You're aggrieved because you don't know how the PTO works. Everyone who knows the workings of the PTO knows that a supervisor makes or breaks your career. It's common knowledge.

References: v. 
 v. 
 §103
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 

v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 § 1447
 v. 
 v. 
 § 1447
 § 1447
 v. 
 v. 
 v.